Try our Advanced Search for more refined results

AstraZeneca CEO Says Inversion Rules Undercut Pfizer Bid

By Karlee Weinmann (November 6, 2014, 12:08 PM EST) -- The CEO of AstraZeneca PLC said Thursday that recent U.S. tax rules diminish the benefits of inversion deals like the one Pfizer Inc. pitched to it earlier this year, dimming the outlook for a renewed Pfizer merger push weeks before the drug giant could make a fresh offer....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!